| Literature DB >> 23395174 |
Sheila A Anderson1, Christopher P Nizzi, Yuan-I Chang, Kathryn M Deck, Paul J Schmidt, Bruno Galy, Alisa Damnernsawad, Aimee T Broman, Christina Kendziorski, Matthias W Hentze, Mark D Fleming, Jing Zhang, Richard S Eisenstein.
Abstract
Red blood cell production is a finely tuned process that requires coordinated oxygen- and iron-dependent regulation of cell differentiation and iron metabolism. Here, we show that translational regulation of hypoxia-inducible factor 2α (HIF-2α) synthesis by iron regulatory protein 1 (IRP1) is critical for controlling erythrocyte number. IRP1-null (Irp1(-/-)) mice display a marked transient polycythemia. HIF-2α messenger RNA (mRNA) is derepressed in kidneys of Irp1(-/-) mice but not in kidneys of Irp2(-/-) mice, leading to increased renal erythropoietin (Epo) mRNA and inappropriately elevated serum Epo levels. Expression of the iron transport genes DCytb, Dmt1, and ferroportin, as well as other HIF-2α targets, is enhanced in Irp1(-/-) duodenum. Analysis of mRNA translation state in the liver revealed IRP1-dependent dysregulation of HIF-2α mRNA translation, whereas IRP2 deficiency derepressed translation of all other known 5' iron response element (IRE)-containing mRNAs expressed in the liver. These results uncover separable physiological roles of each IRP and identify IRP1 as a therapeutic target for manipulating HIF-2α action in hematologic, oncologic, and other disorders.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23395174 PMCID: PMC3612289 DOI: 10.1016/j.cmet.2013.01.007
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287